| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMSB051758 |
| P698 | PubMed publication ID | 16148294 |
| P2093 | author name string | Thomas P Stossel | |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1060-1065 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Regulating academic-industrial research relationships--solving problems or stifling progress? | |
| P478 | volume | 353 |
| Q53106226 | A new era for CNS Spectrums. |
| Q36465802 | A question of method. The ethics of managing conflicts of interest |
| Q53131870 | A reply to Thomas Stossel on the AMA-CEJA draft report. |
| Q36964988 | Academic-industry partnerships in addressing nutrition--[infection-immunity-inflammation] interactions |
| Q38896860 | Association Between Financial Conflicts of Interests and Supportive Opinions for Erectile Dysfunction Treatment. |
| Q42540847 | Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? |
| Q60517540 | Concerned Journals, Editors And ICMJE |
| Q46424297 | Conflict of interest, journal review, and publication policy |
| Q33620440 | Conflicts of interest, authorship, and disclosures in industry-related scientific publications |
| Q24644642 | Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals |
| Q37395133 | Disclosure of financial relationships to participants in clinical research |
| Q35334192 | Extent and implications of the academia-industry connection |
| Q53184205 | Full disclosure--nothing less will do. |
| Q42275125 | Has the hunt for conflicts of interest gone too far? Yes. |
| Q36744141 | How to say "thanks" in Phoenician |
| Q53064994 | Industrial relations with academic health care and professional medical associations: What's all the fuss? Who cares anyway? |
| Q42788212 | Influence of pharmaceutical funding on the conclusions of meta-analyses |
| Q36691339 | Invention, innovation, entrepreneurship in academic medical centers |
| Q36111491 | Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review |
| Q48328081 | Let's get real about conflicts of interest in medicine. |
| Q46106384 | Open innovation networks between academia and industry: an imperative for breakthrough therapies |
| Q36925770 | Perspectives from the symposium: The role of nutrition in infant and toddler brain and behavioral development |
| Q50133431 | Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review |
| Q28288321 | Professional medical organizations and commercial conflicts of interest: ethical issues |
| Q33874709 | Public perceptions of physician - pharmaceutical industry interactions: a systematic review |
| Q33748400 | Research Ethics II: Mentoring, Collaboration, Peer Review, and Data Management and Ownership |
| Q37809934 | Research Ethics III: Publication Practices and Authorship, Conflicts of Interest, and Research Misconduct |
| Q58671322 | Response to AMA's Council on Ethical and Judicial Affairs draft report on "Ethical guidance for physicians and the profession with respect to industry support for professional education in medicine" |
| Q42598652 | Role of physicians in the pharmaceutical industry and clinical research organizations: take more pride in your work |
| Q53108324 | Scientific self-regulation-so good, how can it fail? Commentary on "The problems with forbidding science". |
| Q47253958 | Scientists Still Behaving Badly? A Survey Within Industry and Universities. |
| Q36025608 | Should the financial link between industry and physician consultants be severed? |
| Q35082733 | Standardization and omics science: technical and social dimensions are inseparable and demand symmetrical study |
| Q34025773 | Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications |
| Q37156910 | Tightening conflict-of-interest policies: the impact of 2005 ethics rules at the NIH |
| Q48695226 | Time to 'walk the walk' about industry ties to enhance health |
| Q59210423 | University Research and Public–Private Interaction |
| Q64094757 | Using information literacy to teach medical entrepreneurship and health care economics |
Search more.